ECM1 and neoplasm: The rate of ECM1 copy number amplification was about 19%, 19%, 15%, and 8% in the Clinical Proteomic Tumor Analysis Consortium (CPTAC) (Krug et al. 2020), METABRIC, TCGA, and National Institute of Health and Medical Research (INSERM) (Lefebvre et al. 2016), respectively (Figure 1(C)).